{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:48:13Z","timestamp":1789768093092,"version":"4.0.1"},"reference-count":309,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Relapse remain the leading cause of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with acute myeloid leukemia (AML), despite substantial advances in transplant strategies and supportive care. The dynamics of immune reconstitution (IR) critically determine post-transplant outcomes by shaping the balance between graft-versus-leukemia (GvL) effects, graft-versus-host disease (GvHD), infectious complications, and leukemic immune escape. Importantly, IR is not limited to numerical recovery of immune cells but represents a multidimensional and temporally organized process encompassing quantitative, qualitative, and functional immune restoration. In this review, we provide an integrated clinical laboratory\u2013oriented framework for immune monitoring (IM) after allo-HSCT, with a specific focus on relapse prediction and risk stratification in AML. We discuss the sequential kinetics of innate and adaptive immune recovery, key cellular subsets influencing GvL efficacy, and the impact of transplant-related factors, immunosuppression, and viral reactivations on IR trajectories. Particular emphasis is placed on functional immune states, including T-cell exhaustion, anergy, and senescence, as measurable laboratory correlates of impaired immune surveillance and impending relapse. We further outline current IM methodologies used in routine and advanced clinical laboratories, including multiparameter flow cytometry, measurable residual disease (MRD) assessment, immune repertoire analysis, and emerging omics-based approaches. By integrating immunophenotypic, molecular, and functional data, IM enables earlier detection of relapse-associated immune dysfunction and supports preemptive, risk-adapted therapeutic interventions such as donor lymphocyte infusion or immunomodulatory strategies. Overall, this review highlights the pivotal role of comprehensive, longitudinal immune monitoring in translating complex immunological data into clinically actionable insights. Expanding IM beyond conventional parameters toward integrated, multidimensional approaches is essential for improving relapse prediction, personalizing post-transplant management, and ultimately enhancing long-term outcomes in AML patients undergoing allo-HSCT.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1778853","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T04:21:19Z","timestamp":1775535679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune monitoring for relapse of acute myeloid leukemia after allogeneic stem cell transplantation in clinical laboratories"],"prefix":"10.3389","volume":"17","author":[{"given":"Abdullah","family":"Demir","sequence":"first","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Yeditepe University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"Ayd\u0131n","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Yeditepe University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclderen","family":"Yan\u0131kkaya Demirel","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Yeditepe University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1577924","article-title":"High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation","volume":"16","author":"Pe\u0161i\u0107","year":"2025","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.03.001","article-title":"Temporal evolution of functional immune reconstitution after allogeneic HSCT","volume":"31","author":"Mouton","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.786017","article-title":"Immune reconstitution after allogeneic haematopoietic cell transplantation: From observational studies to targeted interventions","volume":"9","author":"Yanir","year":"2022","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02474-1","article-title":"Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis","volume":"60","author":"Meyer","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.05.011","article-title":"Immune reconstitution after allogeneic stem cell transplantation: Time alone does not heal all wounds","volume":"31","author":"Eyrich","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/BS9.0000000000000261","article-title":"T cell immune reconstitution after allo-HSCT: Key factors and implications","volume":"7","author":"Dai","year":"2025","journal-title":"Blood Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00068","article-title":"Improving engraftment and immune reconstitution in umbilical cord blood transplantation","volume":"5","author":"Danby","year":"2014","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12943-023-01889-6","article-title":"Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: Immune escape mechanisms and current implications for therapy","volume":"22","author":"Sauerer","year":"2023","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00457-z","article-title":"T cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010228","article-title":"Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: prevention, detection, and treatment","volume":"20","author":"Rautenberg","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01672","article-title":"Mass cytometry for the assessment of immune reconstitution after hematopoietic stem cell transplantation","volume":"9","author":"Stern","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02685-5","article-title":"The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia","volume":"39","author":"Rettinger","year":"2025","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016915","article-title":"Harmonized immune recovery monitoring after HCT: Evidence and practical guidance from the Westhafen Intercontinental Group","volume":"9","author":"Hammoudi","year":"2025","journal-title":"Blood Adv"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2025.101634","article-title":"Immune reconstitution following allogeneic hematopoietic cell transplantation and CAR-T therapy: Dynamics, determinants, and directions","volume":"38","author":"Fu","year":"2025","journal-title":"Best Pract Res Clin Haematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.05.038","article-title":"Toward a better understanding of the atypical features of chronic graft-versus-host disease: A report from the 2020 National Institutes of Health Consensus Project Task Force","volume":"28","author":"Cuvelier","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5045\/kjh.2012.47.1.44","article-title":"Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children","volume":"47","author":"Bae","year":"2012","journal-title":"Korean J Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbmt.2015.08.028","article-title":"Immune reconstitution after allogeneic hematopoietic cell transplantation in children","volume":"22","author":"De Koning","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26792","article-title":"The composite immune risk score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases","volume":"98","author":"Cao","year":"2023","journal-title":"Am J Hematol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06663-w","article-title":"Expansion of peripheral helper T cells in the peripheral blood of patients with chronic graft-versus-host disease","volume":"104","author":"Du","year":"2025","journal-title":"Ann Hematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01836-w","article-title":"CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Calderin Sollet","year":"2023","journal-title":"Leukemia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"21029","DOI":"10.1038\/s41598-025-06718-y","article-title":"Functional immune reconstitution after allogeneic hematopoietic stem cell transplantation in myeloablative and non-myeloablative conditioned patients","volume":"15","author":"Brooks","year":"2025","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.89198","article-title":"Assessment of immune reconstitution following hematopoietic stem cell transplantation","volume-title":"Cells of the Immune System","author":"Singh","year":"2020"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0356-4","article-title":"Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD","volume":"17","author":"Blazar","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg3083","article-title":"Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures","volume":"14","author":"Dubouchet","year":"2022","journal-title":"Sci Transl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00500","article-title":"Recent developments in cellular immunotherapy for HSCT-associated complications","volume":"7","author":"Reis","year":"2016","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/v11111049","article-title":"HBV reactivation in patients undergoing hematopoietic stem cell transplantation: A narrative review","volume":"11","author":"Gentile","year":"2019","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.01.005","article-title":"Toward functional immune monitoring in allogeneic stem cell transplant recipients","volume":"26","author":"Naik","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"94.e1","DOI":"10.1016\/j.jtct.2022.10.025","article-title":"Distinct immune reconstitution profiles captured by immune functional assays at 6 months post allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Mouton","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00454","article-title":"Immune monitoring after allogeneic hematopoietic cell transplantation: Toward practical guidelines and standardization","volume":"8","author":"Boelens","year":"2020","journal-title":"Front Pediatr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jcyt.2025.04.069","article-title":"Immune monitoring after cell therapy and hematopoietic cell transplantation: Guidelines by the ISCT Stem Cell Engineering Committee","volume":"27","author":"Oppizzi","year":"2025","journal-title":"Cytotherapy"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601100","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation: Time to T up the thymus","volume":"198","author":"Chaudhry","year":"2017","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285921","article-title":"Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: A prospective cohort study","volume":"110","author":"Kerbauy","year":"2024","journal-title":"Haematologica"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005031","article-title":"Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis","volume":"13","author":"Mushtaq","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01068","article-title":"Improved relapse-free survival in patients with high natural killer cell doses in grafts and during early immune reconstitution after allogeneic stem cell transplantation","volume":"11","author":"Minculescu","year":"2020","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00109","article-title":"Development of three different NK cell subpopulations during immune reconstitution after pediatric allogeneic hematopoietic stem cell transplantation: Prognostic markers in GvHD and viral infections","volume":"8","author":"Huenecke","year":"2017","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01889","article-title":"Thymopoiesis in pre- and post-hematopoietic stem cell transplantation","volume":"9","author":"Rocha","year":"2018","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01341","article-title":"Evaluating thymic function after human hematopoietic stem cell transplantation in the personalized medicine era","volume":"11","author":"Gaballa","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071974","article-title":"Reconstitution of T cell subsets following allogeneic hematopoietic cell transplantation","volume":"12","author":"Dekker","year":"2020","journal-title":"Cancers"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02293-5","article-title":"Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution","volume":"355","author":"Douek","year":"2000","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-176594","article-title":"Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation","volume":"113","author":"Clave","year":"2009","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1210","article-title":"Cytomegalovirus (CMV) cell-mediated immunity and CMV infection after allogeneic hematopoietic cell transplantation: The REACT study","volume":"71","author":"Chemaly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1182\/bloodadvances.2020002735","article-title":"Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses","volume":"5","author":"Fabrizio","year":"2021","journal-title":"Blood Adv"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.05.005","article-title":"Humoral immune reconstitution kinetics after allogeneic hematopoietic stem cell transplantation in children: A maturation block of IgM memory B cells may lead to impaired antibody immune reconstitution","volume":"23","author":"Abdel-Azim","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-025-02702-2","article-title":"Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning","volume":"60","author":"Kolloch","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025705","article-title":"How I treat AML relapse after allogeneic HSCT","volume":"145","author":"Gooptu","year":"2025","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19463","article-title":"Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia","volume":"204","author":"Kinsella","year":"2024","journal-title":"Br J Haematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.31547\/bct-2022-023","article-title":"Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation","volume":"6","author":"Teshima","year":"2023","journal-title":"Blood Cell Ther Off J APBMT"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2021.09.011","article-title":"An ISCT Stem Cell Engineering Committee position statement on immune reconstitution: The importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes","volume":"24","author":"Bertaina","year":"2022","journal-title":"Cytotherapy"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.569381","article-title":"Viral infections in HSCT: Detection, monitoring, clinical management, and immunologic implications","volume":"11","author":"Annaloro","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.58","article-title":"PD-1hiTIM-3+ T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation","volume":"5","author":"Kong","year":"2015","journal-title":"Blood Cancer J"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17182948","article-title":"Dendritic cells of leukemic origin (DCleu) modulate the expression of inhibitory checkpoint molecules and their ligands on T cells and blasts in AML relapse after allogeneic stem cell transplantation","volume":"17","author":"Feng","year":"2025","journal-title":"Cancers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41467-019-08871-1","article-title":"Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT","volume":"10","author":"Noviello","year":"2019","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.664244","article-title":"Immune monitoring for advanced cell therapy trials in transplantation: Which assays and when","volume":"12","author":"Stark","year":"2021","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.celrep.2019.06.049","article-title":"Comprehensive immune monitoring of clinical trials to advance human immunotherapy","volume":"28","author":"Hartmann","year":"2019","journal-title":"Cell Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17122001","article-title":"Blood-based biomarkers as predictive and prognostic factors in immunotherapy-treated patients with solid tumors\u2014currents and perspectives","volume":"17","author":"Kaczmarek","year":"2025","journal-title":"Cancers"},{"key":"B59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12032-025-03002-x","article-title":"Immune profiling in oncology: bridging the gap between technology and treatment","volume":"42","author":"Ravi","year":"2025","journal-title":"Med Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"389","DOI":"10.30574\/wjarr.2022.16.2.1165","article-title":"Analytical method validation: a brief review","volume":"16","author":"Chavan","year":"2022","journal-title":"World J Adv Res Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-015-0086-9","article-title":"Immune monitoring technology primer: clinical validation for predictive markers","volume":"3","author":"Dobbin","year":"2015","journal-title":"J Immunother Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12988","article-title":"Immune monitoring as prerequisite for transplantation tolerance trials","volume":"189","author":"Behnam Sani","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B63","doi-asserted-by":"crossref","DOI":"10.1002\/9781683674023.ch105","article-title":"Immune monitoring during cancer immunotherapy","volume-title":"Manual of Molecular and Clinical Laboratory Immunology","author":"Shehata","year":"2024"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Med (Mex)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision medicine, AI, and the future of personalized health care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin Transl Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coi.2017.08.007","article-title":"Immune monitoring for precision medicine in allergy and asthma","volume":"48","author":"Boyd","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.789","article-title":"Immunometabolism: signaling pathways, homeostasis, and therapeutic targets","volume":"5","author":"Xu","year":"2024","journal-title":"MedComm"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576724","article-title":"Immune monitoring of patients with primary immune regulation disorders unravels higher frequencies of follicular T cells with different profiles that associate with alterations in B cell subsets","volume":"11","author":"Caldirola","year":"2020","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12967-016-0932-7","article-title":"Validation of an IFN\u03b3\/IL2 FluoroSpot assay for clinical trial monitoring","volume":"14","author":"K\u00f6rber","year":"2016","journal-title":"J Transl Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/s41467-024-55746-1","article-title":"Single cell suppression profiling of human regulatory T cells","volume":"16","author":"S\u00f8ndergaard","year":"2025","journal-title":"Nat Commun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2025.102227","article-title":"Recognition of different subsets of alloreactive T cells by activation-induced markers","volume":"90","author":"Betjes","year":"2025","journal-title":"Transpl Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138042","article-title":"Intracellular cytokine staining and flow cytometry: considerations for application in clinical trials of novel tuberculosis vaccines","volume":"10","author":"Smith","year":"2015","journal-title":"PloS One"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103558","article-title":"Protocol for assessing immune-target cell interactions using a single-cell cytotoxicity assay","volume":"6","author":"Wei","year":"2025","journal-title":"STAR Protoc"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01851","article-title":"A flow cytometry-based whole blood natural killer cell cytotoxicity assay using overnight cytokine activation","volume":"11","author":"Kim","year":"2020","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.33696\/haematology.2.039","article-title":"Deep immune status monitoring with multi-color flow cytometry","volume":"2","author":"Wang","year":"2021","journal-title":"J Clin Haematol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24213","article-title":"OMIP\u2010069: forty\u2010color full spectrum flow cytometry panel for deep immunophenotyping of major cell subsets in human peripheral blood","volume":"97","author":"Park","year":"2020","journal-title":"Cytometry A"},{"key":"B77","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/cyto.a.24958","article-title":"Development of a 29\u2010color single\u2010tube full spectrum flow cytometry assay for the detection of measurable residual disease and leukemic stem cells in acute myeloid leukemia","volume":"107","author":"Zhang","year":"2025","journal-title":"Cytometry A"},{"key":"B78","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1038\/s41598-024-57016-y","article-title":"Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological Malignancies","volume":"14","author":"Ip","year":"2024","journal-title":"Sci Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0447-2","article-title":"High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients","volume":"17","author":"Wang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12023","article-title":"Overview of multiplex immunohistochemistry\/immunofluorescence techniques in the era of cancer immunotherapy","volume":"40","author":"Tan","year":"2020","journal-title":"Cancer Commun"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668045","article-title":"Multi-omics approaches in immunological research","volume":"12","author":"Chu","year":"2021","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1038\/s41467-025-57288-6","article-title":"Epigenomic and proteomic analyses provide insights into early-life immune regulation and asthma development in infants","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1470193","article-title":"Proteomic and metabolomic profiling of plasma uncovers immune responses in patients with Long COVID-19","volume":"15","author":"Wei","year":"2024","journal-title":"Front Microbiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1186\/s44342-024-00034-z","article-title":"Comprehensive analysis of TCR and BCR repertoires: insights into methodologies, challenges, and applications","volume":"23","author":"Seo","year":"2025","journal-title":"Genomics Inform"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-019-0084-9","article-title":"RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia\/lymphoma","volume":"4","author":"Farmanbar","year":"2019","journal-title":"NPJ Genomic Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.115.176735","article-title":"IMonitor: a robust pipeline for TCR and BCR repertoire analysis","volume":"201","author":"Zhang","year":"2015","journal-title":"Genetics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12929-022-00879-y","article-title":"Spatial multi-omics analyses of the tumor immune microenvironment","volume":"29","author":"Hsieh","year":"2022","journal-title":"J BioMed Sci"},{"key":"B88","article-title":"LEGENDplexTM: Bead-assisted multiplex cytokine profiling by flow cytometry","volume-title":"Methods in Enzymology","author":"Lehmann","year":"2019"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.3c00513","article-title":"Computational methods in immunology and vaccinology: Design and development of antibodies and immunogens","volume":"19","author":"Guarra","year":"2023","journal-title":"J Chem Theory Comput"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303077120","article-title":"The human cell count and size distribution","volume":"120","author":"Hatton","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S546455","article-title":"The prognostic value of complete blood count-derived inflammatory indicators for all-cause mortality in type 2 diabetes mellitus: a retrospective cohort study","volume":"18","author":"Li","year":"2025","journal-title":"J Inflammation Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"JNCI J Natl Cancer Inst"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15116","article-title":"Early reversal of the lymphocyte\u2010to\u2010monocyte ratio after allogeneic\u2010hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis","volume":"37","author":"Nagayama","year":"2023","journal-title":"Clin Transplant"},{"key":"B94","doi-asserted-by":"publisher","first-page":"18948","DOI":"10.1038\/s41598-022-23344-0","article-title":"Pre-transplant platelet-to- lymphocyte ratio predicts outcome after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Woelfinger","year":"2022","journal-title":"Sci Rep"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2024.2352614","article-title":"Association of the pre-transplant CD4\/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation","volume":"65","author":"Nagayama","year":"2024","journal-title":"Leuk Lymphoma"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13956","article-title":"Adverse impact of a high CD4 \/ CD8 ratio in the allograft may be overcome by methotrexate\u2010 but not mycophenolate\u2010 or post\u2010transplant cyclophosphamide\u2010based graft versus host disease prophylaxis","volume":"110","author":"Nikoloudis","year":"2023","journal-title":"Eur J Haematol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1659077","article-title":"Progenitor-exhausted T cell as prognostic indicator in esophageal squamous cell carcinoma: illuminating their key contribution to tumor immunity","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1198551","article-title":"Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade","volume":"14","author":"Tian","year":"2023","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvae079","article-title":"Cellular senescence: mechanisms and relevance to cancer and aging","volume":"177","author":"Yamauchi","year":"2025","journal-title":"J Biochem (Tokyo)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18632\/oncotarget.28679","article-title":"Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells","volume":"16","author":"Greenberg","year":"2025","journal-title":"Oncotarget"},{"key":"B102","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41392-025-02228-5","article-title":"Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemia","volume":"10","author":"Xie","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01217","article-title":"The graft-versus-leukemia effect in AML","volume":"9","author":"Sweeney","year":"2019","journal-title":"Front Oncol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1038\/s41467-020-17991-y","article-title":"T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e39731","article-title":"Immunoediting in acute myeloid leukemia: reappraising T cell exhaustion and the aberrant antigen processing machinery in leukemogenesis","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"B106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"27649","DOI":"10.1038\/s41598-025-12108-1","article-title":"Ribosomal protein L5 induces cellular senescence via p53-p21-pRb pathway to mediate relapse of acute myeloid leukemia","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3003","article-title":"Characterization of immune dysfunction and identification of prognostic immune-related risk factors in acute myeloid leukemia","volume":"26","author":"Tang","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24900","article-title":"OMIP \u2010109: 45\u2010color full spectrum flow cytometry panel for deep immunophenotyping of the major lineages present in human peripheral blood mononuclear cells with emphasis on the T cell memory compartment","volume":"105","author":"Park","year":"2024","journal-title":"Cytometry A"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24510","article-title":"OMIP\u2010080: 29\u2010color flow cytometry panel for comprehensive evaluation of NK and T cells reconstitution after hematopoietic stem cells transplantation","volume":"101","author":"Vanikova","year":"2022","journal-title":"Cytometry A"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22983","article-title":"OMIP\u2010037: 16\u2010color panel to measure inhibitory receptor signatures from multiple human immune cell subsets","volume":"91","author":"Belkina","year":"2017","journal-title":"Cytometry A"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13090932","article-title":"Immunization strategies in pediatric patients receiving hematopoietic cell transplantation (HCT) and chimeric antigen receptor T-cell (CAR-T) therapy: challenges and insights from a narrative review","volume":"13","author":"Zama","year":"2025","journal-title":"Vaccines"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01373-z","article-title":"Hospitalizations for vaccine-preventable infections among pediatric hematopoietic cell transplantation recipients in the first 5 years after transplantation","volume":"56","author":"Danino","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14100","article-title":"Vaccinations in children with hematologic Malignancies and those receiving hematopoietic stem cell transplants or cellular therapies","volume":"25","author":"Neemann","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14109","article-title":"Vaccine schedule recommendations and updates for patients with hematologic Malignancy post\u2010hematopoietic cell transplant or CAR T\u2010cell therapy","volume":"25","author":"Reynolds","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121449","article-title":"Vaccination after haematopoietic stem cell transplant: a review of the literature and proposed vaccination protocol","volume":"12","author":"Silva-Pinto","year":"2024","journal-title":"Vaccines"},{"key":"B117","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1182\/blood-2025-273","article-title":"Immune reconstitution following memory T-cell add back and prophylactic blinatumomab post TCR\u03b1\u03b2\/CD19-depleted haploidentical transplantation in pediatric patients with high-risk acute leukemia","volume":"146","author":"Suryaprakash","year":"2025","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5030035","article-title":"Role of \u03b1\u03b2 T cell depletion in prevention of graft versus host disease","volume":"5","author":"Abdelhakim","year":"2017","journal-title":"Biomedicines"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103379","article-title":"Hematopoietic stem cell transplantation: recent advances","volume":"14","author":"Milone","year":"2025","journal-title":"J Clin Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2012.13696","article-title":"Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner","volume":"142","author":"Passweg","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/46.8.1221","article-title":"Flow cytometry: principles and clinical applications in hematology","volume":"46","author":"Brown","year":"2000","journal-title":"Clin Chem"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/lymphatics3030023","article-title":"A review of the latest updates in cytogenetic and molecular classification and emerging approaches in identifying abnormalities in acute lymphoblastic leukemia","volume":"3","author":"El Mahdaoui","year":"2025","journal-title":"Lymphatics"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2022.04.012","article-title":"Evolution of HLA testing for hematopoietic stem cell transplantation: importance of the candidate\u2019s antibody profile for donor selection","volume":"83","author":"Bettinotti","year":"2022","journal-title":"Hum Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223855","article-title":"Acute myeloid leukemia: diagnosis and evaluation by flow cytometry","volume":"16","author":"Ally","year":"2024","journal-title":"Cancers"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071111","article-title":"The flow cytometric evaluation of B- and T-lymphoblastic leukemia\/lymphoma","volume":"17","author":"Dorfman","year":"2025","journal-title":"Cancers"},{"key":"B126","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.1182\/blood-2024-210576","article-title":"Combination of minimal residual disease by flow cytometry before and after hematopoietic stem cell transplantation predicts survival in patients with acute myeloid leukemia","volume":"144","author":"Nu\u00f1ez-Torron Stock","year":"2024","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00426-7","article-title":"Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee","volume":"26","author":"Sanz","year":"2025","journal-title":"Lancet Oncol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27597","article-title":"Update in GVHD prophylaxis: novel pharmacologic and graft manipulation strategies","volume":"100","author":"Hexner","year":"2025","journal-title":"Am J Hematol"},{"key":"B130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-031-84988-6_5","article-title":"Optimal GVHD prophylaxis","volume-title":"Clinical Management of Challenges in Allogeneic Stem Cell Transplant","author":"Elmariah","year":"2025"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.25.25322901","article-title":"Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant","author":"Siegel","year":"2025","journal-title":"Oncology"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2023.14.6.5","article-title":"Post-transplant cyclophosphamide for the prevention of graft-vs.-host disease in allogeneic hematopoietic cell transplantation: A guide to management for the advanced practitioner","volume":"14","author":"Kachur","year":"2023","journal-title":"J Adv Pract Oncol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.12.015","article-title":"Early TCR \u03b1\u03b2 and \u03b3\u03b4 repertoire dynamics after myeloablative allo-HCT with post-transplant cyclophosphamide","volume":"32","author":"Krieger","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081853","article-title":"Advancing allogeneic hematopoietic stem cell transplantation outcomes through immunotherapy: A comprehensive review of optimizing non-CAR donor T-lymphocyte infusion strategies","volume":"12","author":"Braidotti","year":"2024","journal-title":"Biomedicines"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021336","article-title":"TCR\u03b1\u03b2\/CD19 cell\u2013depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: Updated final analysis","volume":"143","author":"Merli","year":"2024","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3109\/14653249.2012.715243","article-title":"Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation","volume":"14","author":"Bosch","year":"2012","journal-title":"Cytotherapy"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16355","article-title":"The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience","volume":"188","author":"Loke","year":"2020","journal-title":"Br J Haematol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19924","article-title":"Clinical perspectives on post\u2010induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation","volume":"206","author":"Sweet","year":"2025","journal-title":"Br J Haematol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241915019","article-title":"Novel approaches to treatment of acute myeloid leukemia relapse post allogeneic stem cell transplantation","volume":"24","author":"Liberatore","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.8","article-title":"Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy","volume":"52","author":"Gyurkocza","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/cells14080572","article-title":"Evolution of allogeneic stem cell transplantation: main focus on AML","volume":"14","author":"Inoue","year":"2025","journal-title":"Cells"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02619-1","article-title":"GVHD prophylaxis in matched related stem cell transplantation: why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party","volume":"39","author":"Penack","year":"2025","journal-title":"Leukemia"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.0047","article-title":"Hematopoietic cell transplantation, version 3.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Loren","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02586-7","article-title":"Primary antifungal prophylaxis in hematological Malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)","volume":"39","author":"Pagano","year":"2025","journal-title":"Leukemia"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26503","article-title":"Classification of myeloid neoplasms\/acute leukemia: global perspectives and the international consensus classification approach","volume":"97","author":"Arber","year":"2022","journal-title":"Am J Hematol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.827898","article-title":"Standardization of workflow and flow cytometry panels for quantitative expression profiling of surface antigens on blood leukocyte subsets: an HCDM CDMaps initiative","volume":"13","author":"Ku\u017e\u00edlkov\u00e1","year":"2022","journal-title":"Front Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27625","article-title":"Acute myeloid leukemia: 2025 update on diagnosis, risk\u2010stratification, and management","volume":"100","author":"Shimony","year":"2025","journal-title":"Am J Hematol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2025.101284","article-title":"Low flow: selecting a limited flow cytometry panel where resources are constrained","volume":"72","author":"Ross","year":"2025","journal-title":"Blood Rev"},{"key":"B151","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1016\/j.htct.2024.09.318","article-title":"Analytical validation of a 10-color flow cytometry panel for assessment of measurable residual disease of acute myeloid leukemia","volume":"46","author":"Severino","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282034","article-title":"The present and future of measurable residual disease testing in acute myeloid leukemia","volume":"107","author":"Blachly","year":"2022","journal-title":"Haematologica"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.971709","article-title":"Gamma delta T-cell reconstitution after allogeneic HCT: a platform for cell therapy","volume":"13","author":"Gaballa","year":"2022","journal-title":"Front Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563386","article-title":"Multiplex immunophenotyping of human acute myeloid leukemia patients revealed single-cell heterogeneity with special attention on therapy sensitive and therapy resistant subpopulations","volume":"16","author":"G\u00e9mes","year":"2025","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104506","article-title":"Validation study of analytical methods for multiparameter flow cytometry-based measurable residual disease assessment in acute myeloid leukemia","volume":"26","author":"Barone","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.22084","article-title":"Machine learning optimized multiparameter radar plots for B\u2010cell acute lymphoblastic leukemia minimal residual disease analysis","volume":"102","author":"Shopsowitz","year":"2022","journal-title":"Cytometry B Clin Cytom"},{"key":"B157","doi-asserted-by":"crossref","DOI":"10.1109\/ICAIT61638.2024.10690797","article-title":"Dimensionality reduction using UMAP and TSNE technique","author":"Mittal","year":"2024"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24158","article-title":"A cancer biologist\u2019s primer on machine learning applications in high\u2010dimensional cytometry","volume":"97","author":"Keyes","year":"2020","journal-title":"Cytometry A"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2025-0017","article-title":"Assessing the clinical applicability of dimensionality reduction algorithms in flow cytometry for hematologic Malignancies","volume":"63","author":"Park","year":"2025","journal-title":"Clin Chem Lab Med CCLM"},{"key":"B160","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-2926-0_18","article-title":"A guide on analyzing flow cytometry data using clustering methods and nonlinear dimensionality reduction (tSNE or UMAP)","volume-title":"Neural Repair","author":"Ujas","year":"2023"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100028","article-title":"Comprehensive omics profiling in acute myeloid leukemia: from molecular landscape to clinical translation","volume":"22","author":"Zhang","year":"2025","journal-title":"Curr Proteomics"},{"key":"B162","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10238-025-01858-x","article-title":"Integrating multi-omics approaches in acute myeloid leukemia (AML): advancements and clinical implications","volume":"25","author":"Soleimani Samarkhazan","year":"2025","journal-title":"Clin Exp Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41698-023-00374-z","article-title":"Prediction model for drug response of acute myeloid leukemia patients","volume":"7","author":"Trac","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2025-1715","article-title":"Multi-omics integration reveals therapeutic vulnerabilities and immune microenvironment subtypes in acute myeloid leukemia","volume":"146","author":"Alaterre","year":"2025","journal-title":"Blood"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285057","article-title":"Outcomes and genetic dynamics of acute myeloid leukemia at first relapse","volume":"109","author":"Bataller","year":"2024","journal-title":"Haematologica"},{"key":"B166","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12935-024-03368-4","article-title":"Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes","volume":"24","author":"Kim","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003709","article-title":"Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets","volume":"5","author":"Stratmann","year":"2021","journal-title":"Blood Adv"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01153-0","article-title":"Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia","volume":"35","author":"Rapaport","year":"2021","journal-title":"Leukemia"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003727","article-title":"Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia","volume":"5","author":"Walker","year":"2021","journal-title":"Blood Adv"},{"key":"B170","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2643-3230.BCD-21-0050","article-title":"Genetic and transcriptional contributions to relapse in normal karyotype acute myeloid leukemia","volume":"3","author":"Petti","year":"2022","journal-title":"Blood Cancer Discov"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004962","article-title":"Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression","volume":"6","author":"Stratmann","year":"2022","journal-title":"Blood Adv"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1186\/s12885-024-13286-3","article-title":"Proteomic and metabolomic exploration in relapse acute myeloid leukemia bone marrow supernatant combined with genetic characteristics","volume":"24","author":"Ji","year":"2024","journal-title":"BMC Cancer"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061466","article-title":"The progression of acute myeloid leukemia from first diagnosis to chemoresistant relapse: a comparison of proteomic and phosphoproteomic profiles","volume":"12","author":"Aaseb\u00f8","year":"2020","journal-title":"Cancers"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01796-7","article-title":"Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children","volume":"37","author":"Stratmann","year":"2023","journal-title":"Leukemia"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002981","article-title":"The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker","volume":"5","author":"Lo Presti","year":"2021","journal-title":"Blood Adv"},{"key":"B176","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","article-title":"Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells","volume":"27","author":"Jones","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11090586","article-title":"Metabolic profiling during acute myeloid leukemia progression using paired clinical bone marrow serum samples","volume":"11","author":"Kim","year":"2021","journal-title":"Metabolites"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.259283","article-title":"Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate","volume":"106","author":"Das","year":"2020","journal-title":"Haematologica"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1101\/2023.10.10.561642","article-title":"Convergent epigenetic evolution drives relapse in acute myeloid leukemia","volume":"13","author":"Nuno","year":"2023","journal-title":"eLife"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107620","article-title":"Exploring the impact of methylation aging on acute myeloid leukemia: insights from the aging clock","volume":"148","author":"Kim","year":"2025","journal-title":"Leuk Res"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1359113","article-title":"Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect","volume":"15","author":"Murdock","year":"2024","journal-title":"Front Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061490","article-title":"Pharmacologic strategies for post-transplant maintenance in acute myeloid leukemia: it is time to consider","volume":"14","author":"Abou Dalle","year":"2022","journal-title":"Cancers"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06693-4","article-title":"Current scenario of allogeneic hematopoietic stem cell transplantation in adult patients with relapsed\/refractory acute myeloid leukemia: a narrative review","volume":"104","author":"Huang","year":"2025","journal-title":"Ann Hematol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.596134","article-title":"Pharmacologic therapies to prevent relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Antar","year":"2020","journal-title":"Front Oncol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.287206","article-title":"Prophylactic and pre-emptive donor lymphocyte infusion in patients with acute myeloid leukemia and myelodysplastic syndrome: validation of current recommendations and proposal of a modified outcome assessment","volume":"110","author":"Vel\u00e1zquez","year":"2025","journal-title":"Haematologica"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.10.029","article-title":"Prophylactic versus preemptive donor lymphocyte infusion in refractory\/relapsed AML post-allogeneic transplant: a retrospective comparative study","volume":"32","author":"Wu","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.812207","article-title":"Treatment of AML relapse after allo-HCT","volume":"11","author":"Webster","year":"2021","journal-title":"Front Oncol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1063307","article-title":"Editorial: novel mechanisms for the treatment of AML before and after transplant","volume":"12","author":"Kasner","year":"2022","journal-title":"Front Oncol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2025.103550","article-title":"Chimerism in blood after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: Results from a cohort study","volume":"74","author":"Khemir","year":"2026","journal-title":"Curr Res Transl Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v11.i2.268","article-title":"Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities","volume":"11","author":"Chen","year":"2023","journal-title":"World J Clin cases"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11130","article-title":"Pre-transplant quantitative determination of NPM1 mutation significantly predicts outcome of allogeneic hematopoietic stem cell transplantation in patients with normal karyotype AML in complete remission","volume":"36","author":"Karas","year":"2016","journal-title":"Anticancer Res"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1066285","article-title":"The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia","volume":"12","author":"Maffini","year":"2022","journal-title":"Front Oncol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020359","article-title":"Measurable residual disease and clonal evolution in acute myeloid leukemia from diagnosis to post-transplant follow-up: The role of next-generation sequencing","volume":"11","author":"Sperotto","year":"2023","journal-title":"Biomedicines"},{"key":"B194","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41408-021-00500-9","article-title":"Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia","volume":"11","author":"Kim","year":"2021","journal-title":"Blood Cancer J"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281631","article-title":"Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"108","author":"Rodr\u00edguez-Arbol\u00ed","year":"2022","journal-title":"Haematologica"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013626","article-title":"2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2025.2547993","article-title":"Flow cytometric and molecular MRD in AML: current methods, clinical applications and challenges","volume":"66","author":"Haaksma","year":"2025","journal-title":"Leuk Lymphoma"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02300-z","article-title":"Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance","volume":"38","author":"McCarthy","year":"2024","journal-title":"Leukemia"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02481-2","article-title":"Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice","volume":"60","author":"Shaffer","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1772203","article-title":"Monitoring measurable\/minimal residual disease in acute myeloid leukemia: Multiparametric flow cytometry-based approach","volume":"44","author":"Tembhare","year":"2023","journal-title":"Indian J Med Paediatr Oncol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1093\/stcltm\/szac015","article-title":"Current status and perspectives of allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia","volume":"11","author":"Servais","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030599","article-title":"Measurable residual disease detection in acute myeloid leukemia: Current challenges and future directions","volume":"12","author":"Moritz","year":"2024","journal-title":"Biomedicines"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.666091","article-title":"Optimizing transplant approaches and post-transplant strategies for patients with acute myeloid leukemia","volume":"11","author":"Loke","year":"2021","journal-title":"Front Oncol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2478\/prilozi-2020-0040","article-title":"Molecular monitoring in acute myeloid leukemia patients undergoing matched unrelated donor \u2013 hematopoietic stem cell transplantation: Single center experience","volume":"41","author":"Panovska-Stavridis","year":"2020","journal-title":"PRILOZI"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283120","article-title":"Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia","volume":"108","author":"Swaminathan","year":"2023","journal-title":"Haematologica"},{"key":"B206","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood.2023022697","article-title":"Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation","volume":"144","author":"Wienecke","year":"2024","journal-title":"Blood"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.243410","article-title":"Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3 -internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"105","author":"Bazarbachi","year":"2020","journal-title":"Haematologica"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.04.001","article-title":"SOHO state of the art updates and next questions | Transplanting hope: Managing relapsed\/refractory AML","volume":"25","author":"Funk","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025031480","article-title":"2025 update on MRD in acute myeloid leukemia: A consensus document from the ELN-DAVID MRD Working Party","volume":"147","author":"Cloos","year":"2025","journal-title":"Blood J"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1252258","article-title":"Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges","volume":"15","author":"\u00c1lvarez","year":"2024","journal-title":"Front Immunol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13045-021-01148-5","article-title":"Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia","volume":"14","author":"Aitken","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41408-024-01078-8","article-title":"Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study","volume":"14","author":"Hirsch","year":"2024","journal-title":"Blood Cancer J"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01131-6","article-title":"Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)","volume":"35","author":"Patkar","year":"2021","journal-title":"Leukemia"},{"key":"B214","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41408-018-0148-6","article-title":"Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid Malignancies into clinical routine use","volume":"8","author":"Bacher","year":"2018","journal-title":"Blood Cancer J"},{"key":"B215","doi-asserted-by":"publisher","first-page":"9853","DOI":"10.1038\/s41467-024-54254-6","article-title":"Longitudinal ultra-sensitive mutation burden sequencing for precise minimal residual disease assessment in AML","volume":"15","author":"Wu","year":"2024","journal-title":"Nat Commun"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1805501","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Mauvieux","year":"2018","journal-title":"N Engl J Med"},{"key":"B217","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12308-020-00440-6","article-title":"Molecular methods for measurable residual disease in acute myeloid leukemia: where are we and where are we going","volume":"14","author":"Carlsen","year":"2021","journal-title":"J Hematop"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283790","article-title":"Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax\/azacitidine","volume":"109","author":"Winters","year":"2023","journal-title":"Haematologica"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00655","article-title":"MRD in AML: The role of new techniques","volume":"9","author":"Voso","year":"2019","journal-title":"Front Oncol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12935-019-0807-0","article-title":"The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients","volume":"19","author":"Salehzadeh","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174294","article-title":"MRD monitoring by multiparametric flow cytometry in AML: Is it time to incorporate immune parameters","volume":"14","author":"Pessach","year":"2022","journal-title":"Cancers"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.194712","article-title":"A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia","volume":"104","author":"Onecha","year":"2019","journal-title":"Haematologica"},{"key":"B223","doi-asserted-by":"publisher","first-page":"32679","DOI":"10.1038\/s41598-025-20589-3","article-title":"Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemia","volume":"15","author":"Sommer","year":"2025","journal-title":"Sci Rep"},{"key":"B224","doi-asserted-by":"crossref","first-page":"79","DOI":"10.36255\/exon-publications-leukemia-measurable-residual-disease","article-title":"Measurable residual disease testing in acute leukemia: Technology and clinical significance","volume-title":"Leukemia","author":"Li","year":"2022"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1152467","article-title":"Research topic: Measurable residual disease in hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid Malignancies","volume":"13","author":"Assanto","year":"2023","journal-title":"Front Oncol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.777108","article-title":"Minimal residual disease prior to and after haematopoietic stem cell transplantation in children and adolescents with acute lymphoblastic leukaemia: What level of negativity is relevant","volume":"9","author":"Merli","year":"2021","journal-title":"Front Pediatr"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3897\/folmed.65.e96440","article-title":"A concise review of flow cytometric methods for minimal residual disease assessment in childhood B-cell precursor acute lymphoblastic leukemia","volume":"65","author":"Baldzhieva","year":"2023","journal-title":"Folia Med (Plovdiv)"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-024-00736-9","article-title":"MRD in Philadelphia chromosome-positive ALL: Methodologies and clinical implications","volume":"19","author":"Tran","year":"2024","journal-title":"Curr Hematol Malig Rep"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.603636","article-title":"MRD tailored therapy in AML: What we have learned so far","volume":"10","author":"Ngai","year":"2021","journal-title":"Front Oncol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246121","article-title":"FLT3-ITD measurable residual disease monitoring in acute myeloid leukemia using next-generation sequencing","volume":"14","author":"Lee","year":"2022","journal-title":"Cancers"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27586","article-title":"Breaking the bone marrow barrier: Peripheral blood as a gateway to measurable residual disease detection in acute myelogenous leukemia","volume":"100","author":"Butler","year":"2025","journal-title":"Am J Hematol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"2016052","DOI":"10.4084\/mjhid.2016.052","article-title":"Minimal residual disease in acute myeloid leukemia of adults: Determination, prognostic impact and clinical applications","volume":"8","author":"Del Principe","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110993","article-title":"Prospects and potential for chimerism analysis after allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Miura","year":"2024","journal-title":"Cells"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215431","article-title":"Molecular minimal residual disease detection in acute myeloid leukemia","volume":"13","author":"Vonk","year":"2021","journal-title":"Cancers"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.100","article-title":"Minimal residual disease in acute myeloid leukaemia","volume":"10","author":"Hourigan","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4274\/balkanmedj.galenos.2018.2018.1195","article-title":"The progress of next generation sequencing in the assessment of myeloid Malignancies","volume":"36","author":"\u00d6z Puyan","year":"2019","journal-title":"Balk Med J"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04862-3","article-title":"Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations","volume":"101","author":"KosChade","year":"2022","journal-title":"Ann Hematol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2019.1592673","article-title":"Getting personal with myelodysplastic syndromes: is now the right time","volume":"12","author":"Chokr","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224097","article-title":"Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing","volume":"14","author":"Balagopal","year":"2019","journal-title":"PloS One"},{"key":"B240","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12935-024-03404-3","article-title":"Monitoring measurable residual disease in paediatric acute lymphoblastic leukaemia using immunoglobulin gene clonality based on next-generation sequencing","volume":"24","author":"Ahn","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092477","article-title":"Single-cell next-generation sequencing to monitor hematopoietic stem-cell transplantation: current applications and future perspectives","volume":"15","author":"Ogbue","year":"2023","journal-title":"Cancers"},{"key":"B242","doi-asserted-by":"publisher","first-page":"72","DOI":"10.21833\/ijaas.2023.05.009","article-title":"Minimal residual disease in acute leukemia based on the insight of molecular genetics monitoring","volume":"10","author":"Alyamani","year":"2023","journal-title":"Int J Adv Appl Sci"},{"key":"B243","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40364-025-00869-w","article-title":"Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies","volume":"13","author":"Bancos","year":"2025","journal-title":"biomark Res"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000676","article-title":"Technical aspects of flow cytometry-based measurable residual disease quantification in acute myeloid leukemia: experience of the European LeukemiaNet MRD Working Party","volume":"6","author":"Tettero","year":"2022","journal-title":"HemaSphere"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.01.182","article-title":"Significant inter-laboratory variability in measurable residual disease multiparameter flow cytometry testing prior to allogeneic transplantation impedes outcome prediction: a CIBMTR analysis","volume":"31","author":"Tettero","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2023.05.04","article-title":"MRD-directed and risk-adapted individualized stratified treatment of AML","volume":"35","author":"Zhao","year":"2023","journal-title":"Chin J Cancer Res"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2025.06.004","article-title":"Measurable residual disease monitoring in acute myeloid leukaemia: techniques, timing and therapeutic implications","volume":"62","author":"Croese","year":"2025","journal-title":"Semin Hematol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054790","article-title":"Targeting measurable residual disease (MRD) in acute myeloid leukemia (AML): moving beyond prognostication","volume":"24","author":"Tiong","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051609","article-title":"Prognostic value of measurable residual disease in patients with AML undergoing HSCT: a multicenter study","volume":"15","author":"Caballero-Vel\u00e1zquez","year":"2023","journal-title":"Cancers"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001226","article-title":"Multivariate analysis of immune reconstitution and relapse risk scoring in children receiving allogeneic stem cell transplantation for acute leukemias","volume":"7","author":"Spadea","year":"2021","journal-title":"Transplant Direct"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2024.101566","article-title":"Integration technologies in laboratory information systems: a systematic review","volume":"50","author":"Edayan","year":"2024","journal-title":"Inform Med Unlocked"},{"key":"B252","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10791-025-09505-5","article-title":"Enhancing health information retrieval with RAG by prioritizing topical relevance and factual accuracy","volume":"28","author":"Upadhyay","year":"2025","journal-title":"Discov Comput"},{"key":"B253","doi-asserted-by":"publisher","first-page":"196","DOI":"10.30574\/wjbphs.2025.23.2.0754","article-title":"Modeling spatiotemporal immune dynamics in inflammatory diseases using integrative multi-modal analytics and high-dimensional longitudinal datasets","volume":"23","author":"Adetayo","year":"2025","journal-title":"World J Biol Pharm Health Sci"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1159\/000547767","article-title":"Artificial intelligence in hematopoietic stem cell transplantation care and complication management","volume":"148","author":"Turki","year":"2025","journal-title":"Acta Haematol"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.121867","article-title":"A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies","volume":"3","author":"Ivison","year":"2018","journal-title":"JCI Insight"},{"key":"B256","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/cyto.a.23777","article-title":"Cyt\u2010Geist: current and future challenges in cytometry: reports of the CYTO 2018 conference workshops","volume":"95","author":"Czechowska","year":"2019","journal-title":"Cytometry A"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2017.52","article-title":"Centrally determined standardization of flow cytometry methods reduces interlaboratory variation in a prospective multicenter study","volume":"8","author":"Westera","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"B258","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbt.2019.06.007","article-title":"How standardization of the pre-analytical phase of both research and diagnostic biomaterials can increase reproducibility of biomedical research and diagnostics","volume":"53","author":"Riegman","year":"2019","journal-title":"New Biotechnol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646632","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies*","volume":"47","author":"Cossarizza","year":"2017","journal-title":"Eur J Immunol"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.23664","article-title":"Implementation and validation of an automated flow cytometry analysis pipeline for human immune profiling","volume":"95","author":"Conrad","year":"2019","journal-title":"Cytometry A"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00858","article-title":"Automated analysis of flow cytometry data to reduce inter-lab variation in the detection of major histocompatibility complex multimer-binding T cells","volume":"8","author":"Pedersen","year":"2017","journal-title":"Front Immunol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1282947","article-title":"Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation","volume":"14","author":"Kakodkar","year":"2023","journal-title":"Front Genet"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14040420","article-title":"Validation of artificial intelligence (AI)-assisted flow cytometry analysis for immunological disorders","volume":"14","author":"Lu","year":"2024","journal-title":"Diagnostics"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16497","article-title":"Post\u2010haematopoietic cell transplantation outcomes: why ST2 became a \u2018golden nugget\u2019 biomarker","volume":"192","author":"Paczesny","year":"2021","journal-title":"Br J Haematol"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.70070","article-title":"A pragmatic monitoring model for risk of non\u2010relapse mortality based on biomarkers in patients undergoing allogeneic haematopoietic stem\u2010cell transplantation","volume":"207","author":"Shao","year":"2025","journal-title":"Br J Haematol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.09.005","article-title":"ASTCT consensus recommendations on testing and treatment of patients with donor-specific anti-HLA antibodies","volume":"30","author":"Kongtim","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2022.05.008","article-title":"Immune reconstitution after allogenic stem cell transplantation: an observational study in pediatric patients","volume":"45","author":"Belinovski","year":"2023","journal-title":"Hematol Transfus Cell Ther"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.09.017","article-title":"Allogeneic hematopoietic cell transplantation for the treatment of severe aplastic anemia: evidence-based guidelines from the American Society for Transplantation and Cellular Therapy","volume":"30","author":"Iftikhar","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017999","article-title":"The use of prognostic models in allogeneic transplants: a perspective guide for clinicians and investigators","volume":"141","author":"Sorror","year":"2023","journal-title":"Blood"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30394-X","article-title":"Development and validation of a disease risk stratification system for patients with haematological Malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry","volume":"8","author":"Shouval","year":"2021","journal-title":"Lancet Haematol"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2025.106144","article-title":"A hybrid decision support system using rule-based and AI methods: the OnCATs knowledge-based framework","volume":"206","author":"Domingues","year":"2026","journal-title":"Int J Med Inf"},{"key":"B274","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-16399-0_17","article-title":"Validation of prediction models","volume-title":"Clinical Prediction Models","author":"Steyerberg","year":"2019"},{"key":"B275","doi-asserted-by":"publisher","first-page":"32140","DOI":"10.1038\/s41598-025-17845-x","article-title":"Construction of a prognostic risk model for acute myeloid leukemia based on exosomal genes and analysis of immune microenvironment characteristics","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025015797","article-title":"A revised prognostic model for patients with acute myeloid leukemia and first relapse","volume":"9","author":"Van Der Maas","year":"2025","journal-title":"Blood Adv"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.11.003","article-title":"A practical guide to competing risk analysis for transplant and cell therapy research","author":"Vaquera-Alfaro","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2023.101478","article-title":"The analysis of multiple outcomes, multiple variables and variables selection in hematopoietic cell transplantation studies","volume":"36","author":"Kim","year":"2023","journal-title":"Best Pract Res Clin Haematol"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.70117","article-title":"Machine learning algorithm to explore patients with heterogeneous treatment effects of clinically significant CMV infection and non\u2010relapse mortality after HSCT","volume":"6","author":"Toya","year":"2025","journal-title":"eJHaem"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1002\/sim.70203","article-title":"Combining missing data imputation and internal validation in clinical risk prediction models","volume":"44","author":"Mi","year":"2025","journal-title":"Stat Med"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13172154","article-title":"Explainable AI in clinical decision support systems: a meta-analysis of methods, applications, and usability challenges","volume":"13","author":"Abbas","year":"2025","journal-title":"Healthcare"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2025-0028","article-title":"Artificial intelligence-based predictive model for relapse in acute myeloid leukemia patients following haploidentical hematopoietic cell transplantation","volume":"13","author":"Fan","year":"2025","journal-title":"J Transl Intern Med"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.05.570249","article-title":"Predictive power of machine learning models for relapse outcomes in acute myeloid leukemia: unveiling key genes and pathways for improved patient management","author":"Radak","year":"2023","journal-title":"bioRxiv (Cold Spring Harbor Laboratory)"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300827","article-title":"High-dimensional immune profiles and machine learning may predict acute myeloid leukemia relapse early following transplant","volume":"213","author":"Short","year":"2024","journal-title":"J Immunol"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144021","article-title":"Exploring pattern of relapse in pediatric patients with acute lymphocytic leukemia and acute myeloid leukemia undergoing stem cell transplant using machine learning methods","volume":"13","author":"Shyr","year":"2024","journal-title":"J Clin Med"},{"key":"B286","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12888-023-05214-9","article-title":"Identifying relapse predictors in individual participant data with decision trees","volume":"23","author":"B\u00f6ttcher","year":"2023","journal-title":"BMC Psychiatry"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040898","article-title":"UMAP based anomaly detection for minimal residual disease quantification within acute myeloid leukemia","volume":"14","author":"Weijler","year":"2022","journal-title":"Cancers"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.05.036","article-title":"Application of artificial intelligence in laboratory hematology: advances, challenges, and prospects","volume":"15","author":"Liao","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.22059","article-title":"Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow\u2010Self Organizing Maps algorithm","volume":"102","author":"Porwit","year":"2022","journal-title":"Cytometry B Clin Cytom"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1634935","article-title":"Research advances in the adjunctive diagnosis of acute myeloid leukemia","volume":"15","author":"Xie","year":"2025","journal-title":"Front Oncol"},{"key":"B291","doi-asserted-by":"publisher","first-page":"100373","DOI":"10.1016\/j.modpat.2023.100373","article-title":"Automated deep learning-based diagnosis and molecular characterization of acute myeloid leukemia using flow cytometry","volume":"37","author":"Lewis","year":"2023","journal-title":"Modern Pathology"},{"key":"B292","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1038\/s41598-025-32093-9","article-title":"Application and characterization of the multiple instance learning framework in flow cytometry","volume":"16","author":"Ding","year":"2026","journal-title":"Scientific Reports"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14825","article-title":"Sensitive detection of rare disease-associated cell subsets via representation learning","volume":"8","author":"Arvaniti","year":"2017","journal-title":"Nat Commun"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0316-z","article-title":"A guide to deep learning in healthcare","volume":"25","author":"Esteva","year":"2019","journal-title":"Nat Med"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000016","article-title":"To explain or not to explain?\u2014Artificial intelligence explainability in clinical decision support systems","volume":"1","author":"Amann","year":"2022","journal-title":"PloS Digit Health"},{"key":"B296","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12911-023-02101-x","article-title":"Machine learning-driven clinical decision support system for concept-based searching: a field trial in a Norwegian hospital","volume":"23","author":"Berge","year":"2023","journal-title":"BMC Med Inform Decis Mak"},{"key":"B297","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41408-023-00867-x","article-title":"Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation","volume":"13","author":"Lee","year":"2023","journal-title":"Blood Cancer J"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2025.11.031","article-title":"Coalition of explainable artificial intelligence and quantum computing in precision medicine","volume":"27","author":"Ray","year":"2025","journal-title":"Comput Struct Biotechnol J"},{"key":"B299","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41746-024-01196-4","article-title":"The METRIC-framework for assessing data quality for trustworthy AI in medicine: a systematic review","volume":"7","author":"Schwabe","year":"2024","journal-title":"NPJ Digit Med"},{"key":"B300","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-019-1426-2","article-title":"Key challenges for delivering clinical impact with artificial intelligence","volume":"17","author":"Kelly","year":"2019","journal-title":"BMC Med"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2020.09.060","article-title":"Regulatory frameworks for development and evaluation of artificial intelligence\u2013based diagnostic imaging algorithms: summary and recommendations","volume":"18","author":"Larson","year":"2021","journal-title":"J Am Coll Radiol"},{"key":"B302","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41746-024-01221-6","article-title":"Mapping the regulatory landscape for artificial intelligence in health within the European Union","volume":"7","author":"Schmidt","year":"2024","journal-title":"NPJ Digit Med"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081554","article-title":"FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare","volume":"388","author":"Lekadir","year":"2025","journal-title":"BMJ"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1016\/j.inffus.2025.103812","article-title":"A design framework for operationalizing trustworthy artificial intelligence in healthcare: requirements, tradeoffs and challenges for its clinical adoption","volume":"127","author":"Moreno-S\u00e1nchez","year":"2026","journal-title":"Inf Fusion"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.768113","article-title":"How to prepare spectral flow cytometry datasets for high dimensional data analysis: a practical workflow","volume":"12","author":"Den Braanker","year":"2021","journal-title":"Front Immunol"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1182\/hem.V22.5.202554","article-title":"Technology Spotlight faster, cheaper, better: spectral flow cytometry in the clinical laboratory","volume":"22","author":"Ng","year":"2025","journal-title":"Hematologist"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.704464","article-title":"Mass cytometry in hematologic Malignancies: research highlights and potential clinical applications","volume":"11","author":"Astle","year":"2021","journal-title":"Front Oncol"},{"key":"B308","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41698-025-00897-7","article-title":"Multimodal spatial proteomic profiling in acute myeloid leukemia","volume":"9","author":"Ly","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1287884","article-title":"Flow cytometry and cell sorting","volume":"10","author":"Telford","year":"2023","journal-title":"Front Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T04:21:25Z","timestamp":1775535685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":309,"alternative-id":["10.3389\/fimmu.2026.1778853"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1778853","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"article-number":"1778853"}}